Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Keep Things Straight
View:
Post by SWNE on Aug 07, 2013 7:06pm

Keep Things Straight

Graeme is gambling everything(including our money) on Urocidin.

Graeme grew a marginally good Animal Health business.

Graeme blew a ton of money gambling on Econiche, which has turned into dud city.

All of us investors gambled on Graeme and BNC.

Now, do you hang in, or scramble for the exits? Make up your mind, because we could ultimately see a share price of zero, or many multiples of that........which is still zero. Or, we could get very lucky and make some money. But remember, approval timeframes for Urocidin as seen as two years hence could easily move to 5 years or more, requiring huge more injections of cash coming from prospective partners, whom may ultimately take over Urocidin for less than $5M for us.

This is looking virtually like a lottery with a near zero likehood of a win.

Our better likelihood ending with $1 or $2 per share is to put HH on the back burners, and concentrate on growing AH.

Graeme is obsessed. Are you?
Comment by Nohandledzep on Aug 08, 2013 7:59am
Swine...settle down, Urocidin approval is a slam dunk! You read the BI article...now most CEO's wouldn't make such bold public statements regarding their risk free cancer trials, particularly when they can't even get their HC submission straight, but most CEOs aren't this successful. Endo also knew it was a slam dunk but they fell asleep at the wheel and  Bioniche was able to ...more  
Comment by Pogo3 on Aug 08, 2013 8:39am
It's just too bad we can't believe him. Everything he has told us so far has been a stretch. Slam dunk when? submission will require little to know analysis? their analysis of the parameters for the phase3b trials with ENDO were a smashing sucess?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities